Receive RSS updates from the blog or newsroom.
Latest Posts by Christelle Laot
May 2, 2016
Avoiding clearance delays is critical for temperature-sensitive pharmaceuticals shipments since they risk being spoiled at the port of clearance if no cold chain infrastructure is available. FedEx Express has been investing in cold chain areas at airports to maintain the integrity of delayed international healthcare air shipments. As a matter of fact, the FedEx Express
March 9, 2016
Pharmaceutical markets can be divided into three categories: mature markets, pharmerging markets and underdeveloped markets. The term “pharmerging” is a word that combines pharmaceutical industry and emerging markets. It is used by consultants to describe high-growth pharmaceutical markets, which are generally characterized by a double-digit compound annual growth rate. Within the pharmerging category, China alone accounts for
February 17, 2016
Security is a major concern for pharmaceutical companies, which have a goal to bring safe and effective medicine to patients, but also protect their revenues and brand names. The pharmaceutical supply chain is highly complex, with many components and ingredients being sourced from various countries to the manufacturing plant, and then exported out of the
February 1, 2016
Most foreign shippers are aware that specific documentation requirements such as commercial invoice and the use of appropriate Harmonized Tariff Schedule (HTS) codes are required for a commercial shipment to enter the United States from abroad. When an import shipment is regulated by the Food and Drug Administration (FDA), additional data elements can make the
December 28, 2015
Have you ever heard of PREDICT for FDA import clearance? When a shipment regulated by the Food and Drug Administration (FDA) arrives at the US border, there are two options: It can either be released immediately by the federal agency without further examination, or it can experience a delay at the American port of entry.
November 10, 2015
Healthcare supply chains are becoming increasingly global and complex. Biopharma products are often manufactured in one part of the world and sold in another, while clinical trials are conducted in remote populations with limited access to medicine. As a result, healthcare shipments have to cross borders and even continents for package contents to reach final